Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Sanjiu (Chenzhou) Pharmaceutical, formerly known as Hunan Sanjiu Nankai Pharmaceutical, is a specialized pharmaceutical manufacturer located in Chenzhou, Hunan, China. As a key subsidiary of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., the company is a major production base for Traditional Chinese Medicine (TCM) and over-the-counter (OTC) products under the well-known 999 brand. Its diverse product portfolio features Binglian Qingyan Spray for pharyngitis and Zhining Tablets for hemorrhoids, as well as treatments for gynecological and digestive disorders. The company operates advanced GMP-certified facilities that handle large-scale TCM extraction and the production of various solid dosage forms. With a history dating back to 1992, it plays a vital role in the supply chain of one of China's largest pharmaceutical groups. The firm continues to focus on the modernization of traditional medicine and the expansion of its commercial footprint across domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan 39 Nankai Pharmaceutical.